Biopharma case studies Archives - Insights https://news.mayocliniclabs.com/category/biopharma/biopharma-case-studies/ Get the latest news and education from Mayo Clinic Laboratories Thu, 19 Sep 2024 13:41:06 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.2 Thermo Fisher Scientific: Illuminating rare cancer prognosis and improving patients’ lives https://news.mayocliniclabs.com/2024/09/16/thermo-fisher-scientific-illuminating-rare-cancer-prognosis-and-improving-patients-lives/ https://news.mayocliniclabs.com/2024/09/16/thermo-fisher-scientific-illuminating-rare-cancer-prognosis-and-improving-patients-lives/#respond Mon, 16 Sep 2024 13:00:00 +0000 https://news.mayocliniclabs.com/?p=112418 Thermo Fisher Scientific: Illuminating rare cancer prognosis and improving patients’ livesAiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of a novel, automated assay aimed at detecting a biomarker associated with the progressive disease.

The post Thermo Fisher Scientific: Illuminating rare cancer prognosis and improving patients’ lives appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/09/16/thermo-fisher-scientific-illuminating-rare-cancer-prognosis-and-improving-patients-lives/feed/ 0 Neurology study validates Alzheimer’s assays https://news.mayocliniclabs.com/2024/06/10/neurology-study-validates-alzheimers-assays/ https://news.mayocliniclabs.com/2024/06/10/neurology-study-validates-alzheimers-assays/#respond Mon, 10 Jun 2024 12:00:00 +0000 https://news.mayocliniclabs.com/?p=110505 Neurology study validates Alzheimer’s assaysMayo Clinic Laboratories’ BioPharma Diagnostics team facilitates specimen collections and access to archived samples to support clinical trials and diagnostic validation projects that advance healthcare. In this collaboration example, learn how BioPharma Diagnostics helped a research healthcare company evaluate the clinical performance of three assays designed to aid in the diagnosis of Alzheimer’s disease and other causes of cognitive impairment.

The post Neurology study validates Alzheimer’s assays appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/06/10/neurology-study-validates-alzheimers-assays/feed/ 0 Oncology surveillance biomarker study enrolls patients and evaluates assay https://news.mayocliniclabs.com/2024/05/27/oncology-surveillance-biomarker-study-enrolls-patients-and-evaluates-assay/ https://news.mayocliniclabs.com/2024/05/27/oncology-surveillance-biomarker-study-enrolls-patients-and-evaluates-assay/#respond Mon, 27 May 2024 12:00:00 +0000 https://news.mayocliniclabs.com/?p=110502 Oncology surveillance biomarker study enrolls patients and evaluates assayMayo Clinic Laboratories’ BioPharma Diagnostics team supports companies from discovery to post-market in advancing their precision medicine initiatives. In this collaboration example, learn how BioPharma Diagnostics helped a biotech company complete a surveillance biomarker study to establish a cutoff for its assay developed to monitor the progression or regression of disease in patients with well-defined gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

The post Oncology surveillance biomarker study enrolls patients and evaluates assay appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/05/27/oncology-surveillance-biomarker-study-enrolls-patients-and-evaluates-assay/feed/ 0 Infectious disease test gains U.S. FDA approval https://news.mayocliniclabs.com/2024/05/13/infectious-disease-test-gains-u-s-fda-approval/ https://news.mayocliniclabs.com/2024/05/13/infectious-disease-test-gains-u-s-fda-approval/#respond Mon, 13 May 2024 12:00:00 +0000 https://news.mayocliniclabs.com/?p=110499 Infectious disease test gains U.S. FDA approvalAn ideal testing partner will offer extensive expertise in assay development and analytical validation services, along with access to biospecimens. In this collaboration example, learn how Mayo Clinic Laboratories’ BioPharma Diagnostics team helped a musculoskeletal diagnostics company complete a prospective study to demonstrate its test’s performance in detecting periprosthetic joint infection (PJI) in synovial fluid.

The post Infectious disease test gains U.S. FDA approval appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/05/13/infectious-disease-test-gains-u-s-fda-approval/feed/ 0 Gastrointestinal study collects and tests patient specimens at multiple touchpoints https://news.mayocliniclabs.com/2024/04/29/gastrointestinal-study-collects-and-tests-patient-specimens-at-multiple-touchpoints/ https://news.mayocliniclabs.com/2024/04/29/gastrointestinal-study-collects-and-tests-patient-specimens-at-multiple-touchpoints/#respond Mon, 29 Apr 2024 12:00:00 +0000 https://news.mayocliniclabs.com/?p=110490 Gastrointestinal study collects and tests patient specimens at multiple touchpointsMayo Clinic Laboratories’ BioPharma Diagnostics team collaborates with biopharmaceutical, diagnostic, and other research companies to offer a wide range of laboratory testing and biopharma support for all phases of clinical trials. In this collaboration example, learn how BioPharma Diagnostics helped an international diagnostics company complete a study of patients with liver cirrhosis with the goal of validating a specific serum metabolite constellation to detect early hepatocellular carcinoma (HCC) lesions in liver cirrhosis.

The post Gastrointestinal study collects and tests patient specimens at multiple touchpoints appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/04/29/gastrointestinal-study-collects-and-tests-patient-specimens-at-multiple-touchpoints/feed/ 0